Dyne Therapeutics (DYN) PT Raised to $44 at Oppenheimer; 'Expectations Exceeded Across the Board'
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $44.00 (from $34.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
